Joe Ndukwe, Director, KOL Marketing, Urovant Sciences, Inc.
Overactive bladder (OAB) is a prevalent syndrome that often goes misdiagnosed or untreated. At Urovant Sciences, Joe Ndukwe is constructing a roadmap for professional strategy and thought leader engagement. His team executes initiatives that bridge educational gaps within Urology, Primary Care, and Long-Term Care medical communities.
In addition to elevating foundational knowledge of OAB, education highlights GEMTESA® (vibegron) 75 mg tablets, a prescription medication for treatment of OAB in adults with symptoms of urge urinary incontinence, urgency, and frequency.
To date, Joe’s team has engaged with a diverse base of opinion leaders to help execute 14 national product theater symposiums at key society meetings and to help deliver 160 local speaker programs enriching education for a base of 3,000+ healthcare providers (HCPs).
With unparalleled devotion, Joe has been able to harness diversity of thought and drive achievement through collaboration, which has helped HCPs elevate urologic patient care.
